GNGeorgios Nikolopoulos

Georgios Nikolopoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Georgios Nikolopoulos has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic Screening of a Nonsyndromic Amelogenesis Imperfecta Patient Cohort Using a Custom smMIP Reagent for Selective Enrichment of Target Loci

    by Ummey Hany, Christopher M. Watson, Lu Liu, Georgios Nikolopoulos, Claire E. L. Smith, James A. Poulter, Agne Antanaviciute, Alice Rigby, Richard Balmer, Catriona J. Brown, et al.

    Amelogenesis is the process of tooth enamel formation, and genetic variants disrupting it cause the Mendelian inherited disorder amelogenesis imperfecta (AI). AI patients have weak, discoloured or brittle enamel, caused by reduced enamel quantity or mineralisation. AI can occur in isolation or, less commonly, as part of a syndrome. Pathogenic variants in at least 38 genes have been shown to cause AI. Current genetic screening studies typically use exome sequencing, but this is expensive and involves complex data analysis workflows. Target enrichment using smMIPs (single molecule molecular inversion probes) provides a flexible alternative, allowing the creation of a disease‐specific reagent for low cost, robust, high‐throughput screening. Here, we describe the development of an smMIP reagent targeting 19 genes implicated in isolated AI and assess its use in screening a cohort of 181 UK probands with nonsyndromic AI. While this was intended only as a prescreen to prioritise exome sequencing more efficiently, it nevertheless led to molecular diagnoses for 63 probands (35%). Cost per sample screened was approximately £40. Variants in three genes, COL17A1, FAM83H (both dominant) and MMP20 (recessive), accounted for approximately half of solved cases. There is scope to further improve the smMIP reagent by adding additional probes targeting regions of low coverage or additional genes, including those involved in syndromic AI, as well as accommodating new information about the genetic basis of AI. The smMIP reagent provides a robust, flexible, high‐throughput, low‐cost approach to AI screening, and it is available as a resource to the international AI research community.


  • Open Access

    Spectrum of pathogenic variants and founder effects in amelogenesis imperfecta associated with MMP20

    by Georgios Nikolopoulos, Claire E. L. Smith, James A. Poulter, Gina Murillo, Sandra Silva, Teresa Lamb, Ian R. Berry, Catriona J. Brown, Peter F. Day, Francesca Soldani, et al.

    Amelogenesis imperfecta (AI) describes a heterogeneous group of developmental enamel defects that typically have Mendelian inheritance. Exome sequencing of ten families with recessive hypomaturation AI revealed 4 novel and 1 known variants in the matrix metallopeptidase 20 (MMP20) gene that were predicted to be pathogenic. MMP20 encodes a protease that cleaves the developing extracellular enamel matrix and is necessary for normal enamel crystal growth during amelogenesis. New homozygous missense changes were shared between four families of Pakistani heritage (c.625G>C; p.(Glu209Gln)) and two of Omani origin (c.710C>A; p.(Ser237Tyr)). In two families of UK origin and one from Costa Rica, affected individuals were homozygous for the previously reported c.954‐2A>T; p.(Ile319Phefs*19) variant. For each of these variants, microsatellite haplotypes appeared to exclude a recent founder effect, but elements of haplotype were conserved, suggesting more distant founding ancestors. New compound heterozygous changes were identified in one family of European heritage; c.809_811+12delinsCCAG; p.(?) and c.1122A>C; p.(Gln374His). This report further elucidates the mutation spectrum of MMP20 and the probable impact on protein function, confirms a consistent hypomaturation phenotype and shows that mutations in MMP20 are a common cause of autosomal recessive AI in some communities.


  • Open Access

    Spectrum of pathogenic variants and multiple founder effects in amelogenesis imperfecta associated with MMP20

    by Georgios Nikolopoulos, Claire E. L. Smith, James A. Poulter, Gina Murillo, Sandra Silva, Catriona J. Brown, Peter F. Day, Francesca Soldani, Suhaila Al-Bahlani, Sarah A. Harris, et al.

    Amelogenesis imperfecta (AI) describes a heterogeneous group of developmental enamel defects that typically have Mendelian inheritance. Exome sequencing of ten families with recessive hypomaturation AI revealed 4 novel and 1 known variants in the matrix metallopeptidase 20 ( MMP20 ) gene that were predicted to be pathogenic. MMP20 encodes a protease that cleaves the developing extracellular enamel matrix and is necessary for normal enamel crystal growth during amelogenesis. New homozygous missense changes were shared between four families of Pakistani heritage (c.625G>C; p.(E209Q)) and two of Omani origin (c.710C>A; p.(S237Y)). In two families of UK origin and one from Costa Rica, affected individuals were homozygous for the previously reported c.954-2A>T; p.(I319Ffs*19) variant. For each of these variants, microsatellite haplotypes appeared to exclude a recent founder effect, but elements of haplotype were conserved, suggesting more distant founding ancestors. New compound heterozygous changes were identified in one family of European heritage; c.809_811+12delACGgtaagattattainsCCAG; p.(?) and c.1122A>C; p.(Q374H). All four new variants are within the zinc dependant peptidase domain. This report further elucidates the mutation spectrum of MMP20 and the probable impact on protein function, confirms a consistent hypomaturation phenotype and shows that mutations in MMP20 are a common cause of autosomal recessive AI in some communities. Data Availability: The data that support the findings of this study are openly available in ClinVar at https://www.ncbi.nlm.nih.gov/clinvar/ , accession numbers: SCV001338799 - SCV001338802 and in the AI Leiden Open Variation Database (LOVD) at http://dna2.leeds.ac.uk/LOVD/ with reference numbers: 0000000313 – 0000000317.

  • Open Access

    New missense variants in RELT causing hypomineralised amelogenesis imperfecta

    by Georgios Nikolopoulos, Claire E.L. Smith, Steven J. Brookes, Mohammed E. El‐Asrag, Catriona J. Brown, Anesha Patel, Gina Murillo, Mary J. O'COnnell, Chris F. Inglehearn, Alan J. Mighell

    Amelogenesis imperfecta (AI) is a heterogeneous group of genetic diseases characterised by dental enamel malformation. Pathogenic variants in at least 33 genes cause syndromic or non‐syndromic AI. Recently variants in RELT, encoding an orphan receptor in the tumour necrosis factor (TNF) superfamily, were found to cause recessive AI, as part of a syndrome encompassing small stature and severe childhood infections. Here we describe four additional families with autosomal recessive hypomineralised AI due to previously unreported homozygous mutations in RELT. Three families carried a homozygous missense variant in the fourth exon (c.164C>T, p.(T55I)) and a fourth family carried a homozygous missense variant in the 11th exon (c.1264C>T, p.(R422W)). We found no evidence of additional syndromic symptoms in affected individuals. Analyses of tooth microstructure with computerised tomography and scanning electron microscopy suggest a role for RELT in ameloblasts' coordination and interaction with the enamel matrix. Microsatellite genotyping in families segregating the T55I variant reveals a shared founder haplotype. These findings extend the RELT pathogenic variant spectrum, reveal a founder mutation in the UK Pakistani population and provide detailed analysis of human teeth affected by this hypomineralised phenotype, but do not support a possible syndromic presentation in all those with RELT‐variant associated AI.


  • Open Access

    A quantitative method for the high throughput screening for the soil adhesion properties of plant and microbial polysaccharides and exudates

    by Jumana Akhtar, Andrew F. Galloway, Georgios Nikolopoulos, Katie J. Field, Paul Knox

    Background and aims Understanding the structures and functions of carbon-based molecules in soils is an important goal in the context of soils as an ecosystem function of immense importance. Polysaccharides are implicated in maintaining soil aggregate status but have not been extensively dissected in terms of their structures and soil adhesion properties. This is largely because of the technical difficulties in identifying polysaccharide structures and quantifying any functional properties. Methods Here, we describe the use of a novel nitrocellulose-based adhesion assay to determine the relative capacities for soil adhesion of over twenty plant and microbial polysaccharides that are likely to be present in soil and to contribute to organic matter content and properties. Weights of soil adhered to spots of known amounts of specific polysaccharides were quantified by scanning of the nitrocellulose sheets. Results The most effective polysaccharides identified from this survey included chitosan, β-1,3-glucan, gum tragacanth, xanthan and xyloglucan. We also demonstrate that the soil adhesion assay is suitable to assess the soil-binding properties of plant exudates. Conclusions The soil adhesion assay will be useful for the functional dissection of the organic matter components of soils and also of the factors involved in soil attachment to plant roots and in rhizosheath formation.